August 25, 2025 - 23:00

The U.S. government is exploring the use of machine-learning technology to develop AI-generated propaganda campaigns aimed at influencing foreign audiences. According to a recent Pentagon document, this initiative is part of a broader strategy to manage information and suppress dissenting opinions in various regions. The document outlines plans to utilize advanced algorithms to create persuasive narratives that align with U.S. interests.
Officials believe that leveraging artificial intelligence can enhance the effectiveness of information operations, allowing for more targeted messaging and rapid dissemination of content. This approach seeks to counteract opposing viewpoints and narratives that could undermine U.S. objectives abroad. The initiative raises ethical questions about the role of AI in shaping public perception and the potential consequences of deploying such technologies in international contexts. As the U.S. navigates complex global dynamics, the implications of using AI for propaganda purposes will likely spark debate among policymakers, technologists, and the public.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...